(27) tested the lupus anticoagulant (LA), anticardiolipin (aCL), and anti-β2 glycoprotein I (aβ2GPI) antibodies in patients with primary antiphospholipid syndrome after vaccination and reported that CoronaVac did not cause thrombosis or induce changes in aPL production. This evidence concerns the gene ACLY and antiphospholipid syndrome.